Premium
Clofazimine (B663, Geigy) in Leprosy Reactions
Author(s) -
Smith R. B. W.
Publication year - 1972
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.1972.tb00480.x
Subject(s) - clofazimine , dapsone , leprosy , medicine , dermatology , clinical trial , surgery
SUMMARY Ten Solomon Island patients with troublesome leprosy reactions were treated with clofazimine in an uncontrolled clinical trial. In every case benefit resulted to the patient in one or more of the following ways: clofazimine had the ability to suppress reactions; to replace cortico‐steroid therapy; to cover the effect of increasing the dosage of dapsone; and to produce clinical improvement without serious side effects.